Company / Current Liabilities
NEUROONE MEDICAL TECHNOLOGIES Corp Current Liabilities History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$2.3M
FY2025
5-year range
$1.8M / $3.1M
FY2021-FY2025
Trend
+4.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $2M to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2025 with a 10-year CAGR of +39.4%.
Increased from $2M to $2M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -9.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- +39.4%
Key checks
Key Insights
- 3-year CAGR of -9.4%, indicating a declining trend.
- In FY2025, current liabilities increased 4.1% year-over-year.
- Peak current liabilities was recorded in FY2022.
- Lowest current liabilities in the period was in FY2011.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.3M | +4.1% |
| FY2024 | $2.2M | +23.5% |
| FY2023 | $1.8M | -42.1% |
| FY2022 | $3.1M | +31.5% |
| FY2021 | $2.4M | +1897.8% |
| FY2016 | $117.9K | +41.5% |
| FY2015 | $83.3K | +134.1% |
| FY2014 | $35.6K | +93.9% |
| FY2012 | $18.4K | +296.6% |
| FY2011 | $4.6K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026